Moleculomics has launched its flagship in silico drug discovery platform, Human3DProteome.
Human3DProteome is a comprehensive platform for whole system drug discovery, drug repurposing and toxicity screening.
Human3DProteome is a breakthrough technology for rapid discovery of better and safer drug compounds – a comprehensive in silico platform of the entire human proteome (all the receptors, enzymes etc., encoded by the human genome), providing a unique molecular level structural database including detailed characterisation of active sites and millions of protein-compound interactions. It is a powerful open-ended, virtual lead discovery environment, and the only in silico platform that allows for screening against all receptor drug targets and for off-target interactions of a compound against the whole proteome.
Visit Human3DProteome.com
